Re-evaluating colistin: A critical tool against multidrug-resistant gram-negative bacteria

References

1. El-Sayed Ahmed MAE, Zhong L, Shen C, Yang Y, Doi Y, Tian G. Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019). Emerg Microbe Infect. 2020;9(1):868–85.
2. Alotaibi FM, Alshehail BM, Al Jamea ZAH, Joseph R, Alanazi AH, Alhamed NA, et al. Incidence and Risk Factors of Colistin-Induced Nephrotoxicity Associated with The International Consensus Guidelines for the Optimal Use of the Polymyxins: A Retrospective Study in a Tertiary Care Hospital, Saudi Arabia. Antibiotics. 2022;11(11):1569.
3. Liu Y, Wang Y, Walsh TR, Yi L, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161–
4. Chauhan S, Shinu P, Kaur N, Saini AK, Bala R, Nair AB, et al. Dynamics of Antimicrobial Susceptibility and Risk Factors Associated with Infections Caused by Colistin-Resistant Bacteria: A Study from the Northern Region of Haryana, India. Pol J Microbiol. 2025;74(1):95–105.
5. Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, et al. Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51–77.